Rockwell Medical Technologies Inc. (NASDAQ: RMTI) seeing unusual options intensity as 1,801 February $10 calls change versus OI of 10, with buyers leading the way in multiple large lots, as shares change for $8.77. RMTI is in the impact of Phase 2b studies for its iron equal therapy for dialysis patients, calles SFP for short. Results are exxpected in Q1 of 2010, likely the reason for using February calls in this trade. Phase 3 is expected to start in Q4 of this year, and some Phase 2b data should be free by the end of September. The intensity is 500X the cipher call intensity for Rockwell.
JOE KUNKLE, OptionsHawk.com
No comments:
Post a Comment